tirzepatide updates today Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Important Tirzepatide Update! As the

Pause or stop whenever you need to

When to Contact Your PlexusDx Provider About Sweating Most sweating related to GLP-1 therapy is mild and self-limiting, but you should reach out if you experience drenching night sweats that soak through clothing and bedding, sweating accompanied by fever or chills, or sweating that develops suddenly after weeks of stable treatment

Maintaining a fixed injection dayideally the same day each weekallows your healthcare provider to accurately monitor how your body responds to your current dose

1 The KESIMPTA Phase 2 trial determined that once monthly frequency in a low SC dose was comparably effective, with fewer side effects, vs higher SC doses